Delivery Order SPE2DB24D2010-SPE2DB25FAAFM

Award Date 7/8/25
Potential Completion Date 7/9/25
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order worth $34,232.81 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The Firm Fixed Price contract, which has an ultimate completion date of December 20, 2024, is for the delivery of 4566771042 - PROLIA 60 MG/ML SYRINGEML. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PROLIA 60 MG/ML SYRINGEML, a pharmaceutical product, with an ultimate completion date of July 2, 2025 and a ceiling value of $22,182.71. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,975.84, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a prescription medication. The contract is not set aside and is a firm fixed-price, delivery order. It has an ultimate completion date of April 18, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $11,685.72 firm fixed-price delivery order is for the supply of PROLIA 60 MG/ML SYRINGE ML, a pharmaceutical product. The contract has an ultimate completion date of July 9, 2025. Amerisourcebergen Drug Corp is a large, for-profit corporate entity that serves as a critical supplier of medical and pharmaceutical...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,714.50, is for the delivery of PROLIA 60 MG/ML SYRINGEML, a prescription medication, to support federal medical requirements. The contract has an ultimate completion date of June 5, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with a ceiling value of $3,214.35 and a performance period through July 10, 2025. This contract is not set aside and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award is a delivery order valued at $13,538.09, awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA), a defense agency. The contract provides for the delivery of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with an ultimate completion date of June 24, 2025. The contract is a firm fixed-price arrangement without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a $7,613.02 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract is for the provision of PROLIA 60 MG/ML SYRINGE, a pharmaceutical product, with a period of performance through June 5, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROLIA 60 MG/ML SYRINGEML. The contract has a firm fixed price of $13,176.99 and a period of performance through August 1, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for delivering a...
This is a delivery order federal contract award valued at $5,131.04, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROLIA 60 MG/ML SYRINGE syringes and is a firm fixed-price contract with a completion date of June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FAAFM
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,559.10 firm fixed-price contract is for the supply of PROLIA 60 MG/ML SYRINGE ML, a pharmaceutical product. The delivery order has an ultimate completion date of July 9, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support various government agencies, including the Defense Health Agency and U.S. Coast Guard. The contract award is not designated as a set-aside.

Generated 10/7/25, 9:58 AM